1951 — Jinxin Fertility Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual income statement for Jinxin Fertility, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,426	1,839	2,364	2,789	2,812
Cost of Revenue
Gross Profit	566	771	874	1,175	1,099
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,064	1,350	2,134	2,250	2,367
Operating Profit	363	489	231	539	444
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	349	458	154	464	392
Provision for Income Taxes
Net Income After Taxes	260	354	118	347	273
Minority Interest
Net Income Before Extraordinary Items
Net Income	252	340	121	345	283
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	252	340	126	335	283
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.1	0.136	0.057	0.123	0.104
Dividends per Share